Midland Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$700K Buy
1,934
+37
+2% +$12.7K 0.03% 87
2026
Q1
$667K Buy
1,897
+3
+0.2% +$1.07K 0.03% 90
2025
Q4
$620K Sell
1,894
-132
-7% -$41.9K 0.03% 95
2025
Q3
$572K Sell
2,026
-613
-23% -$178K 0.03% 106
2025
Q2
$737K Buy
2,639
+437
+20% +$124K 0.04% 93
2025
Q1
$686K Sell
2,202
-256
-10% -$75.6K 0.04% 104
2024
Q4
$641K Sell
2,458
-284
-10% -$84.3K 0.04% 116
2024
Q3
$884K Sell
2,742
-508
-16% -$166K 0.05% 101
2024
Q2
$1.02M Sell
3,250
-67
-2% -$19.7K 0.06% 87
2024
Q1
$943K Buy
3,317
+192
+6% +$56.2K 0.06% 90
2023
Q4
$900K Buy
+3,125
New +$851K 0.06% 95

Other funds holding AMGN

Midland Wealth Advisors's AMGN Position: Q2 2026 in Review

Midland Wealth Advisors increased its Amgen (AMGN) stake by 2% in Q2 2026, buying an estimated $12.7K and bringing the position to 1,934 shares worth $700K. The position accounts for 0.03% of the portfolio, ranked #87.

Midland Wealth Advisors first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.02M in Q2 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Midland Wealth Advisors held 1,934 shares of Amgen worth $700K as of Q2 2026.
  • Midland Wealth Advisors bought 37 Amgen shares in Q2 2026, an estimated $12.7K.
  • Amgen made up 0.03% of Midland Wealth Advisors's portfolio in Q2 2026, its #87 holding.
  • Midland Wealth Advisors first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • Midland Wealth Advisors's Amgen position peaked at $1.02M in Q2 2024.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Midland Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.